Skip to content

Our story Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Headquartered in Stockholm, we employ around 9,000 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. Since 1995 , we have supported pharmaceutical companies in taking their products from early development through to commercial manufacturing. Throughout the entire product lifecycle, we are there for our clients. Time and time again, we have delivered innovative solutions.

You must be logged in to view further information.

Need help?

Contact us on james.williamson@naame.co.uk to find out more about NAAME, our Talent Sharing Platform or Manufacturing Groups.